Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ANGO — AngioDynamics, Inc.
NASDAQ
FULL STOCK PAGE →

Q3 2026 Earnings Call Summary

APR 2, 2026
REVENUE
$78.4M -1.3%
NET MARGIN
-10.3% -2.3 PTS
EPS
-$0.19 -26.7%
FREE CASH FLOW
-$4.1M -197.3%

No summary has been written for this call yet.